HIGHLIGHTS
- who: Glucocorticoids and colleagues from the Medicine, University Hospital Basel, Petersgraben, Basel, Switzerland have published the research work: Corticosteroid treatment for community-acquired pneumonia - the STEP trial: study protocol for a randomized controlled trial, in the Journal: (JOURNAL) of 15/Oct/2013
- what: The study has adequate power for the clinically relevant endpoint of clinical stability. The aim of this trial is to evaluate whether treatment with prednisone for seven days in patients with CAP as compared to placebo reduces time to clinical stability.
- how: Prednisolone is the pharmacologically active metabolite of prednisone . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.